Healthcare >> CEO Interviews >> September 13, 2002
KAROLY NIKOLICH, PhD, Founder and CEO, founded AGY Therapeutics with
Robert Swanson, former founding CEO of Genentech, in 1998. Dr. Nikolich
has 19 years of biotechnology industry experience and is an expert in
the study of central nervous system disease; he has authored over 100
scientific publications on his work. Prior to founding AGY Therapeutics,
Dr. Nikolich served as Vice President of Research at Lynx Therapeutics,
Inc., a technology-based genomics company. From 1983, he worked in the
research division of Genentech, Inc. for 12 years, where he initiated,
established and directed Genentech's neuroscience research program. Dr.
Nikolich graduated from Eotvos University in Budapest, Hungary, and
completed a post-doctoral fellowship at Tulane University as well as a
visiting scholarship at the University of California, San Francisco. Profile
the company's forte?
Dr. Nikolich: AGY Therapeutics is focused on discovering and developing
novel treatments for
